Its the first once-daily GLP-1 pill that has shown results similar to injectable versions
While some people respond to taking a very small dose called super responders others cannot tolerate moving up to the next higher standard dose and need something in between. This helps explain why one recent study among patients with diabetes found that microdosing helped them stick with their GLP-1s, reducing side effects without compromising efficacy
Stop taking it and seek medical advice if you develop symptoms such as abdominal pain, dark urine, or yellowing of the skin or eyes
Dietary patterns that support GLP-1 biology may also help people tolerate GLP-1 receptor agonist (GLP-1RA) therapy by reducing gastrointestinal side effects, which are a frequent reason for discontinuation in clinical practice
Factors include the peptide sequence, molecular weight, lyophilization conditions, and the concentration of the resulting solution
Stay connected with friends, family, or support groups